Metraipolis › archive › dc_6c6ca38ec7be
Patient-derived prostate cancer organoids: model development, therapeutic applications, and challenges for precision oncology — Europe PMC PMID:42827781
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42827781
- DOI
- 10.3389/fonc.2026.1939330
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:50:41.042Z
- SHA-256 of the archived text
313200a318b80099505c2875c6dc0cd333f7dbcf9652652ff4eb8302d97e2e80- Stable URL of this page
https://metraipolis.com/documento/dc_6c6ca38ec7be
How to cite
Patient-derived prostate cancer organoids: model development, therapeutic applications, and challenges for precision oncology — Europe PMC PMID:42827781 — Europe PMC (en), https://europepmc.org/article/MED/42827781 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6c6ca38ec7be (Metraipolis archive dc_6c6ca38ec7be, sha256 313200a318b80099505c2875c6dc0cd333f7dbcf9652652ff4eb8302d97e2e80)
BibTeX
@misc{dc6c6ca38ec7be,
title = {Patient-derived prostate cancer organoids: model development, therapeutic applications, and challenges for precision oncology — Europe PMC PMID:42827781},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42827781},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6c6ca38ec7be; sha256 313200a318b80099505c2875c6dc0cd333f7dbcf9652652ff4eb8302d97e2e80},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42827781. Agents can read the archived copy with the MCP tool read_document.